InsideTracker, a Cambridge, MA-based healthspan optimization platform provider, raised $15M in Series B funding.
The round was led by PeakBridge with participation from Cornucopian Capital, OurCrowd, BASF Venture Capital GmbH, and existing investors.
The company intends to use the funds to expand operations and its business reach.
Led by Rony Sellam, InsideTracker integrates biomarker data from blood, DNA, activity trackers, and user-generated demographic information to create science-backed recommendations to optimize healthspan—i.e., help users live healthier longer—and systematically achieve their health and wellness goals.
Powered by a proprietary AI engine, InsideTracker combines machine learning and computational biology with more than 60,000 human-hours of meta-analysis and curation from the company’s cross-disciplinary team of scientists and subject matter experts. Ongoing research, development, and calibration of the engine is led by Renee Deehan, PhD, Vice President of Science and Artificial Intelligence; Gil Blander, PhD, Founder and Chief Scientific Officer; and a team of scientific advisory board members including recent additions Eran Segal, PhD, and Ali Torkamani, PhD.
FinSMEs
09/09/2022